This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 Oct 2011

J&J Reports Financial Results for Q3

Johnson & Johnson has announced its financial results for the third quarter this year with sales of $16.0 billion, an increase of 6.8% as compared to the third quarter of 2010.

US health care giant Johnson & Johnson announced Tuesday sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. 


Operational results increased 2.6% and the positive impact of currency was 4.2%.  Domestic sales declined 3.7%.  International sales increased 16.4%, reflecting operational growth of 8.3% and a positive currency impact of 8.1%.


Net earnings and diluted earnings per share for the third quarter of 2011 were $3.2 billion and $1.15, respectively.  Third-quarter 2011 net earnings also included an after-tax mark-to-market adjustment to the value of the currency option associated with the planned acquisition of Synthes, Inc.  Excluding special items, net earnings fo

Related News